Enzymatic production and functional characterization of d-sorbitol monoesters with various fatty acids
摘要:
Sugar fatty acid esters are surfactants that are widely used in food, cosmetics, and pharmaceutical industries. In this study, enzymatic production of o-sorbitol monoesters with various fatty acids (C10-C18) was assessed. Reactions were performed in tert-butanol at 40 degrees C, catalyzed by Candida sp. 99-125 lipase. Dissolution of the substrates was found to be the limiting step of the reaction, and hence preheating was performed to increase the solubility of D-sorbitol. Thus, the yield of D-sorbitol palmitate was increased from 734 to 31.6 mM. The results demonstrated that the specific lipase preferred long-chain fatty acids. The surface-active properties. of the products were also determined. (C) 2015 Published by Elsevier B.V.
CRYSTALLINE D-ISOGLUTAMYL-D-TRYPTOPHAN AND THE MONO AMMONIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN
申请人:Tam Tim Fat
公开号:US20100016243A1
公开(公告)日:2010-01-21
A process for making pure crystalline D-isoglutamyl-D-tryptophan is provided which includes the step of deprotecting essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan or its diester to yield essentially pure D-isoglutamyl-D-tryptophan. A process is also provided for the preparation of pure mono ammonium salt of D-isoglutamyl-D-tryptophan from essentially pure N-tert-butoxycarbonyl-D-isoglutamyl-D-tryptophan. D-isoglutamyl-D-tryptophan, ammonium salt (1:1) is a stable pharmaceutical solid.
The present invention relates to a fluoroallylamine derivative and use thereof. In particular, the present invention relates to a compound as shown in Formula I, a prodrug, an isomer, an isotope-labeled compound, a solvate or a pharmaceutically acceptable salt thereof, which has VAP-1/SSAO inhibitory activity, and can be used for treating a disease associated with VAP-1/SSAO overactivity.
[EN] RENEWABLE ACRYLIC ACID PRODUCTION AND PRODUCTS MADE THEREFROM<br/>[FR] PRODUCTION D'ACIDE ACRYLIQUE RENOUVELABLE ET PRODUITS FABRIQUÉS À PARTIR DE CELUI-CI
申请人:METABOLIX INC
公开号:WO2013185009A1
公开(公告)日:2013-12-12
Processes and methods for making biobased acrylic acid products including acrylic acid, acrylic acid oligomers, acrylic acid esters, acrylic acid polymers and articles from renewable carbon resources are described herein.
The present invention relates to a process for treating human keratin fibers and/or the skin from which the said fibers emerge, in order to induce and/or stimulate the growth of the human keratin fibers and/or to stop their loss and/or to increase their density, comprising at least the application, to the human keratin fibers and/or the skin, of a cosmetic composition comprising an effective amount of at least one piperidine derivative of general formula (I),
in which:
R
1
denotes a halogen or a radical chosen from a linear or branched C
1
-C
6
alkyl radical, a group OR, a group NRR′, a CF
3
group, a group NHCOR or a group CONRR′;
R
2
denotes a linear or branched C
1
-C
20
alkyl or alkenyl radical, the hydrocarbon-based chain of which may be optionally interrupted with a —CO— function optionally substituted with at least one group OR, COOR, NRR′, NHCOR or CONRR′ and/or with a phenyl group optionally substituted with one or more radicals R
1
;
with R and R′ denoting, independently of each other, a hydrogen atom or a linear or branched C
1
-C
6
alkyl radical,
m represents an integer ranging from 0 to 5; and n represents an integer ranging from 0 to 5. or a salt or isomer thereof, leaving the said composition in contact with the keratin fibers and/or the skin from which the fibers emerge, and optionally rinsing the keratin fibers and/or the skin.
Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers
申请人:Rozot Roger
公开号:US20070092467A1
公开(公告)日:2007-04-26
Oxyacetamide compounds that are inhibitors of type-1 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and which have the formula (I), or salts and/or solvates thereof:
are useful for inducing and/or stimulating the growth of human keratin fibers, e.g., human head hair and/or eyelashes, and/or for retarding the loss and/or increasing the density thereof and/or for caring for and/or making up such keratin fibers.